Management of Prostate Cancer (Current Clinical Urology) - Hardcover

 
9781588293046: Management of Prostate Cancer (Current Clinical Urology)

Inhaltsangabe

Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5–10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual’s chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, radical prostatectomy vs observation); (5) a focus on the biology of bone and bone metastasis, and new agents that reduce skeletal-related events and which may inhibit the growth of new metastases; (6) second-generation anti-PSMA antibodies with improved potential for imaging and therapy; (7) the development and widespread adoption of nomograms that assist in cli- cal decision-making for individual patients; (8) the identification of new genes that

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Von der hinteren Coverseite

In this second edition of his popular and widely acclaimed book, Eric Klein, MD, and a panel of leading authorities have thoroughly updated and revised its contents to include all the latest observations and developments that will shape the direction of clinical practice and research over the next 5-10 years. Here, the reader will find in concise form accounts of the latest trends in diagnosis and mortality, new PSA isoforms for diagnosis, PSA screening, chemoprevention, biopsy techniques, sural nerve grafting, and hereditary prostate cancer. Additional chapters reflect progress in the management of locally advanced disease, the use of nomograms to predict outcomes, the medical management of erectile dysfunction, brachytherapy, and deciding between surgery and radiation. The chapters on open and laparoscopic techniques, the selection of candidates for observation, pathological analysis, quality of life, and the management of rising PSA after definitive therapy have been extensively updated. A compact disk accompanies the book for downloading an ebook to the reader's PC or PDA. Up-to-date and eminently practice-oriented, Management of Prostate Cancer, Second Edition, offers every physician-especially front-line urologists, radiation therapists, and medical oncologists-concise and authoritative guidance on today's best therapeutic regimens for the diagnosis and treatment of prostate cancer.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.